This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pulvermacher, S. C.
Right arrow Articles by Stauffer, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pulvermacher, S. C.
Right arrow Articles by Stauffer, G. V.

 Previous Article  |  Next Article 

Journal of Bacteriology, January 2009, p. 238-248, Vol. 191, No. 1
0021-9193/09/$08.00+0     doi:10.1128/JB.00915-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

The Small RNA GcvB Regulates sstT mRNA Expression in Escherichia coli{triangledown}

Sarah C. Pulvermacher, Lorraine T. Stauffer, and George V. Stauffer*

Department of Microbiology, University of Iowa, Iowa City, Iowa 52242

Received 2 July 2008/ Accepted 9 October 2008


arrow
ABSTRACT
 
In Escherichia coli, the gcvB gene encodes a nontranslated RNA (referred to as GcvB) that regulates OppA and DppA, two periplasmic binding proteins for the oligopeptide and dipeptide transport systems. An additional regulatory target of GcvB, sstT, was found by microarray analysis of RNA isolated from a wild-type strain and a gcvB deletion strain grown to mid-log phase in Luria-Bertani broth. The SstT protein functions to transport L-serine and L-threonine by sodium transport into the cell. Reverse transcription-PCR and translational fusions confirmed that GcvB negatively regulates sstT mRNA levels in cells grown in Luria-Bertani broth. A series of transcriptional fusions identified a region of sstT mRNA upstream of the ribosome binding site needed for negative regulation by GcvB. Analysis of the GcvB RNA identified a sequence complementary to this region of the sstT mRNA. The region of GcvB complementary to sstT mRNA is the same region of GcvB identified to regulate the dppA and oppA mRNAs. Mutations predicted to disrupt base pairing between sstT mRNA and GcvB were made in gcvB, which resulted in the identification of a small region of GcvB necessary for negative regulation of sstT-lacZ. Additionally, the RNA chaperone protein Hfq was found to be necessary for GcvB to negatively regulate sstT-lacZ in Luria-Bertani broth and glucose minimal medium supplemented with glycine. The sstT mRNA is the first target found to be regulated by GcvB in glucose minimal medium supplemented with glycine.


arrow
INTRODUCTION
 
The Escherichia coli chromosome encodes 50 to 100 small, nontranslated RNAs (sRNAs) (excluding tRNAs and 5S RNA) that function using diverse mechanisms under a variety of cellular conditions (2, 7, 36-39). A number of these sRNAs have been found to function as regulators in response to different growth conditions including various osmolarities, temperatures, oxidative stresses, and iron levels (37). A large class of sRNAs bind to the RNA chaperone protein Hfq (12, 28). Many of these sRNAs that bind Hfq regulate expression of target genes posttranscriptionally by base pairing with target mRNAs (12, 28). Base pairing between the sRNA and target mRNA can result in an alteration in the stability or translation of the message (7, 29, 37). It is unclear how extensive base pairing between an sRNA and a target mRNA must be, but research indicates that one or two regions of 8 to 9 bp are sufficient for regulation (7). Single mutations made in the target mRNA ompC in the region of complementarity with the sRNA MicC or with mutations made in the target mRNA ptsG in the region of complementarity with the sRNA SgrS interfered with regulation (5, 12). These sRNAs were found to regulate these target mRNAs by base pairing (5, 12). Other examples of sRNAs that bind Hfq and regulate target mRNAs by base pairing include MicF, DsrA, RprA, RyhB, DicF, OxyS, and Spot42 (5, 7, 8, 28). In most cases base pairing results in negative regulation of translation activity and decreased stability of the target mRNA (7).

The gcvB gene encodes an sRNA of 206 nucleotides that, in turn, regulates oppA and dppA mRNAs, which encode the oligopeptide and dipeptide periplasmic binding proteins, respectively (33). The sRNA RyhB is known to regulate at least 18 different target mRNAs (16), and many other sRNAs are also predicted to regulate more than one target. In addition, in Salmonella, GcvB has been shown to regulate livK, livJ, argT, gltI, dppA, and oppA mRNAs by direct interactions (24). Therefore, we predicted that GcvB in E. coli has additional regulatory targets other than the oppA and dppA mRNAs. We compared RNA isolated from a wild-type strain and a gcvB deletion strain grown to mid-log phase in Luria-Bertani (LB) broth by microarray analysis to identify any additional regulatory targets of GcvB. One potential target identified by microarray analysis was sstT, which encodes a Na+/L-serine and L-threonine transport protein. Similar to DppA and OppA, SstT also functions to transport nutrients into the cell (19) and is the principal serine transporter thought to be constitutively expressed in E. coli K-12 (13, 18). A GU-rich region in GcvB previously identified to base pair with dppA and oppA mRNAs (21) and shown to be necessary for regulation of seven target mRNAs in Salmonella (24) was found to be complementary with sstT mRNA upstream of the ribosome binding site. On the basis of the dppA and oppA regulation by GcvB in E. coli (21), we hypothesized that GcvB and mRNA pairing is also the regulatory mechanism employed by GcvB for negative regulation of sstT mRNA and that this regulation is dependent upon Hfq. This study shows that GcvB negatively regulates sstT mRNA in an Hfq-dependent mechanism in cells grown in both LB medium and defined glucose minimal medium.


arrow
MATERIALS AND METHODS
 
Bacterial strains, plasmids, and phage. The E. coli strains, plasmids, and bacteriophages used in this study are listed in Table 1 or described in the text. Strains GS1148 and GS1149 were constructed by transduction. P1clr phage grown on the hfq-1::{Omega}Cmr strain GS081 was used to transduce strains GS162 and GS1132 to Cmr, generating strains GS1148 and GS1149, respectively. Plasmid pGS609, carrying the E. coli hfq gene, was constructed as follows. In a PCR, HindIII primer 1 hybridized to a region beginning 992 bp upstream of the Hfq translation start site, and HindIII primer 2 hybridized to a region beginning 109 bp downstream of the Hfq translation stop codon. PCR amplification was carried out using Vent DNA polymerase (New England Biolabs, Inc., Beverly, MA). Cycling conditions were as follows: 1 min and 30 s of denaturation at 95°C, 1 min of annealing at 55°C, and 2 min of extension at 72°C for 30 cycles. The 1,409-bp PCR-generated HindIII fragment was cloned into the HindIII site in plasmid pACYC177 (4) and was verified by DNA sequence analysis at the DNA Core Facility of the University of Iowa.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Strains, plasmids, and bacteriophages

Five {lambda}sstT-lacZ transcriptional fusions were constructed by synthesis of DNA fragments with either BamHI or EcoRI sites at bp –386 upstream of the sstT translational start codon and five different fusion points with HindIII sites at bp –66, –40, –24, –18, and –13 upstream of the translation start codon. Following digestion with BamHI and HindIII or with EcoRI and HindIII, the DNA fragments were gel purified and ligated into the BamHI and HindIII or the EcoRI and HindIII sites of plasmid pgcvB(+50)-lacZ (where +50 is the nucleotide position of the fusion in gcvB) (33), replacing the gcvB fragment with the sstT fragments and generating intermediate plasmids psstT(–66)-lacZ, psstT(–40)-lacZ, psstT(–24)-lacZ, psstT(–18)-lacZ, and psstT(–13)-lacZ. An EcoRI-MfeI DNA fragment carrying each sstT-lacZ fusion and the lacYA genes was gel purified and ligated into the EcoRI site of phage {lambda}gt2. The phage isolates were designated {lambda}sstT(–66)-lacZ, {lambda}sstT(–40)-lacZ, {lambda}sstT(–24)-lacZ, {lambda}sstT(–18)-lacZ, and {lambda}sstT(–13)-lacZ (Table 1 and Fig. 1A). The {lambda}sstT-lacZ translational fusion phage was constructed in a similar manner except that the upstream primer contained an EcoRI site at bp –386, and the downstream primer contained an SmaI site at codon 9 within the sstT structural gene. Following EcoRI-SmaI digestion, the DNA fragment was gel purified and ligated into the EcoRI and SmaI sites of plasmid pMC1403 (3), fusing the sstT structural gene in frame with the eighth codon of the lacZYA genes. The intermediate plasmid was designated psstT-lacZ. The translational fusion was cloned into {lambda}gt2 as described above, and the resulting phage was designated {lambda}sstT-lacZ (Table 1 and Fig. 1A). All fusion sequences were verified by DNA sequence analysis at the DNA Core Facility of the University of Iowa. The phage were used to lysogenize various E. coli host strains as described previously (32). Each lysogen was tested to ensure that it carried a single copy of the {lambda} chromosome by infection with {lambda}cI90c17 (25). All lysogens were grown at 30°C since all fusion phage carry the {lambda}cI857 mutation, resulting in a temperature-sensitive {lambda}cI repressor (20).


Figure 1
View larger version (12K):
[in this window]
[in a new window]

  		FIG. 1. (A) The sstT gene sequence including the promoter –35, –10, and +1 start sites; the Shine-Dalgarno (SD); and the ATG translational start site (19). The sites of the translational fusion and five transcriptional fusions are indicated by arrows below the sequence. (B) Comparison of GcvB between nucleotides +60 and +100 with the sstT mRNA. The AUG translational start site for sstT mRNA is underlined. The Shine-Dalgarno sequence is overlined and labeled SD. A 13-base region of GcvB from nucleotide +79 to +91 conserved in GcvB homologs from the genera Escherichia, Salmonella, Yersinia, Haemophilus, Vibrio, Pasteurella, Shigella, Klebsiella, and Photorhabdus is underlined. Regions of complementarity are indicated with dots between the sequences. GU base pairs are indicated by a line. The transcriptional fusions sstT(–24)-lacZ, sstT(–18)-lacZ, and sstT(–13)-lacZ are indicated with red arrowheads. Changes made to GcvB are indicated below the sequence. A 1-nucleotide and an 11-nucleotide deletion are indicated with {Delta}s. A 7-nucleotide random substitution in the conserved region, designated GcvB(+79ACAAgAgAA), is indicated in brown. An AAA mutation made to GcvB, designated GcvB(+76AAA), is shown in pink. Single mutations made to the 4-nucleotide region in the conserved region are shown in black below the brown sequence. These mutations include GcvB(+79C), GcvB(+80C), GcvB(+81C), and GcvB(+82A). A combined 4-nucleotide CCCA mutation is shown in dark green and is designated GcvB(+79CCCA). A 5-nucleotide UCUCC mutation is shown in light blue and is designated GcvB(+83UCUCC). Compensatory mutations in sstT to restore base pairing with mutants GcvB(+76AAA), GcvB(+83UCUCC), and GcvB(+79ACAAgAgAA) are shown above the sstT sequence in the corresponding colors. The A nucleotide of the translation initiation codon in sstT mRNA is designated +1. Mutations upstream of the translation initiation sites are defined as negative numbers, and mutations downstream of the translation initiation sites are defined with positive numbers.

Mutagenesis. Using plasmid pGS571 (gcvB) and plasmid psstT-lacZ as templates, the PCR megaprimer mutagenesis procedure (23) was used to create nucleotide changes in the gcvB gene and sstT gene (Fig. 1B and Table 1). Mutations were verified by DNA sequence analysis at the DNA Core Facility of the University of Iowa. The gcvB mutations were subcloned into the single-copy-number plasmid pGS341, replacing the gcvA gene. The sstT mutations were cloned into {lambda}gt2, and the phage was used to lysogenize appropriate host strains as described previously (32).

Media. The complex medium used was LB (17). Agar was added at 1.5% (wt/vol) to make solid medium. The minimal medium used was the salts of Vogel and Bonner (35) supplemented with 0.4% (wt/vol) glucose (glucose medium [GM]). Supplements were added at the following concentrations (in µg ml–1): ampicillin (Amp), 50; chloramphenicol (Cm), 20; glycine, 300; inosine, 50; L-serine, 400.

DNA manipulation. The procedures for plasmid DNA purification and restriction enzyme digestion were as described previously (22). PCR amplifications were carried out under standard reaction conditions using Vent DNA polymerase (New England BioLabs, Inc., Beverly, MA). Restriction enzymes and other DNA modifying enzymes were from New England Biolabs, Inc. (Beverly, MA).

Enzyme assays. β-Galactosidase assays were performed on mid-log-phase cells (optical density at 600 nm of ~ 0.5) using a chloroform-sodium dodecyl sulfate lysis procedure (17). Results are the averages of two or more assays, with each sample done in triplicate.

RNA isolation and Northern blot analysis. Appropriate E. coli strains were grown in 5 ml of LB medium to an optical density at 600 nm of ~ 0.5 and treated with a 1/5 volume of stop solution (95% ethanol-5% acidic phenol); cultures were centrifuged at 2,000 x g for 5 min, and cell pellets were frozen at –80°C. Total RNA was isolated by phenol extraction (15), and each RNA sample was DNase I treated for 1 h at 37°C. RNA was quantified using a NanoDrop ND-1000 Spectrophotometer. For Northern blot analysis, 10 µg of total RNA was run on an 8 M urea-8% polyacrylamide gel and electroblotted to a positively charged nylon membrane (Roche, Mannheim, Germany). The blot was hybridized with a DNA probe specific to nucleotides +1 to +134 of the E. coli gcvB gene labeled using a PCR-DIG Probe synthesis kit (Roche, Mannheim, Germany). Hybridization was performed at 42°C as described previously (6), and the membrane was exposed to film and imaged using a Fujifilm LAS-1000 camera and Intelligent Dark Box. Quantification of RNA was performed using the software Image Gauge, version 3.12. The membrane was subsequently stripped using 0.1% (wt/vol) sodium dodecyl sulfate-2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), heated to ~95°C, and rehybridized using a digoxigenin-labeled DNA probe specific to 5S RNA from nucleotides +2 to +112. The relative amount of GcvB expressed from each mutant gcvB allele was determined by taking the ratio of the GcvB to 5S RNA detected for each sample.

Serine growth curve. Wild-type (GS162), {Delta}gcvB (GS1144), and complemented {Delta}gcvB pgcvB+ (GS1144 [pGS594]) strains were grown overnight in 2 ml of GM. Overnight cultures were used to inoculate 5 ml of GM or 5 ml of GM plus L-serine (Amp was added to the transformed strain for both conditions). L-Serine was always made the day before a growth curve and added at 400 µg ml–1 immediately prior to the growth curve experiment. Cell density was read every 30 min using a Klett-Summerson reader until cultures reached mid-log phase of growth. The growth curve was repeated three times, and the averages are reported.


arrow
RESULTS
 
GcvB represses sstT mRNA and an sstT-lacZ translational fusion in LB medium. Microarray analysis of RNA isolated from a wild-type strain and an otherwise isogenic {Delta}gcvB strain grown in LB medium suggested that sstT mRNA is negatively regulated ~8.5-fold by GcvB (data not shown). To initially confirm that sstT mRNA is negatively regulated by GcvB, we performed semiquantitative reverse transcription-PCR. We observed a higher level of DNA corresponding to the sstT gene fragment amplified from cDNA generated from total RNA isolated from the {Delta}gcvB strain than from either the wild-type or the complemented {Delta}gcvB strain (data not shown), indicating that GcvB negatively regulates sstT mRNA in cells grown in LB medium to mid-log phase of growth.

To further confirm that GcvB negatively regulates sstT mRNA, we made a translational fusion of sstT with lacZ (Fig. 1A), cloned this fusion into {lambda}gt2, and lysogenized the wild-type, {Delta}gcvB, and the complemented {Delta}gcvB pgcvB+ strains. These lysogenic strains were grown in LB medium (with Amp for the complemented strain) to the mid-log phase of growth and assayed for β-galactosidase activity. Expression of sstT-lacZ in the wild-type lysogen was ~12-fold lower than expression in the {Delta}gcvB lysogen (Fig. 2A, lanes 1 and 2). Repression of sstT-lacZ was restored in the complemented {Delta}gcvB pgcvB+ lysogen (Fig. 2A, lane 3). These results confirm that sstT mRNA is an additional regulatory target of GcvB in wild-type cells grown in LB medium.


Figure 2
View larger version (36K):
[in this window]
[in a new window]

  		FIG. 2. Effects of GcvB on sstT-lacZ translational and transcriptional fusions. (A) β-Galactosidase levels from the {lambda}sstT-lacZ translational fusion from the wild-type (GS162), {Delta}gcvB (GS1144), {Delta}gcvB pgcvB+ (GS1144 [pGS594]), or {Delta}gcvB strain complemented with mutated gcvB alleles shown in Fig. 1B. (B) β-Galactosidase activity levels from the transcriptional fusions {lambda}sstT(–66)-lacZ, {lambda}sstT(–40)-lacZ, {lambda}sstT(–24)-lacZ, {lambda}sstT(–18)-lacZ, and {lambda}sstT(–13)-lacZ in the wild-type (black), {Delta}gcvB (white), or {Delta}gcvB pgcvB+ (gray) strain. (C) β-Galactosidase levels from the {lambda}sstT-lacZ translational fusion from the wild-type, {Delta}gcvB, {Delta}gcvB pgcvB+, or {Delta}gcvB strain complemented with a mutated gcvB allele shown in Fig. 1B. (D) β-Galactosidase activity levels of {lambda}sstT-lacZ, {lambda}sstT(–18AGAGG)-lacZ, and {lambda}sstT(–14UGUUcUcUU)-lacZ translational fusions from either the wild-type, {Delta}gcvB, or the {Delta}gcvB lysogen complemented with pgcvB+, pgcvB(+83UCUCC), or pgcvB(+79ACAAgAgAA) alleles. (E) β-Galactosidase activity levels of the {lambda}sstT(–11UUU)-lacZ translational fusion from the wild-type, {Delta}gcvB, or the {Delta}gcvB lysogen complemented with pgcvB+ or pgcvB(+76AAA) alleles. (F) β-Galactosidase levels from the {lambda}sstT-lacZ translational fusion from the wild-type, {Delta}hfq (GS1148), {Delta}gcvAB {Delta}hfq (GS1149), and {Delta}hfq phfq++ (GS1148 [pGS609]) lysogens. Results are the averages of two or more assays, with each assay performed in triplicate.

GcvB regulates sstT-lacZ in cultures grown in GM with glycine. GcvB has a negative role in controlling oppA-phoA and dppA-lacZ expression in cells grown in LB medium (33). However, when cells were grown in GM supplemented with glycine, GcvB showed no significant repression of either oppA-phoA or dppA-lacZ fusions, with 1.1- and 1.6-fold repression observed, respectively (33). Previous results found gcvB-lacZ to be expressed ~8-fold higher in wild-type cells grown in GM with glycine than in GM alone, ~25-fold higher than in wild-type cells grown in GM with inosine (33), and ~4-fold higher than wild-type cells grown in GM with L-serine (data not shown), suggesting that GcvB is differentially regulated in different GM combinations. Additionally, by Northern blot analysis we observed GcvB RNA from wild-type cells grown GM with glycine but not from wild-type cells grown in GM or GM supplemented with inosine (S.C. Pulvermacher, L. T. Stauffer, and G. V. Stauffer, unpublished data). The amount of GcvB detected in wild-type cells grown in GM with glycine was ca. eightfold lower than wild-type cells grown in LB medium (Pulvermacher et al., unpublished). Because of the dramatic differences in GcvB expression observed among wild-type cells grown in these different media, we hypothesized that there are regulatory targets for GcvB in wild-type cells grown in GM with glycine. Therefore, we tested whether GcvB regulates the sstT-lacZ translational fusion in GM supplemented with glycine. The wild-type, {Delta}gcvB, and the complemented {Delta}gcvB pgcvB+ lysogens were grown in GM with glycine to the mid-log phase of growth and assayed for β-galactosidase activity. Expression of sstT-lacZ was approximately twofold lower in the wild-type lysogen than in the {Delta}gcvB lysogen, and repression of sstT-lacZ was restored in the complemented {Delta}gcvB pgcvB+ lysogen (Fig. 3A). The results suggest that although slight, GcvB is able to regulate sstT-lacZ in GM supplemented with glycine, but the range of regulation is considerably less than for cells grown in LB medium.


Figure 3
View larger version (20K):
[in this window]
[in a new window]

  		FIG. 3. Effects of GcvB and Hfq on the sstT-lacZ translational fusion in defined medium. (A) β-Galactosidase levels from the {lambda}sstT-lacZ translational fusion in the wild-type (GS162), {Delta}gcvB (GS1144), {Delta}hfq (GS1148), {Delta}gcvAB {Delta}hfq (GS1149), {Delta}gcvB pgcvB+ (GS1144 [pGS594]), or {Delta}hfq phfq++ (GS1148 [pGS609]) strain grown in GM with glycine. (B) β-Galactosidase levels from the wild-type {lambda}sstT-lacZ translational lysogen grown in the indicated media. Results are the averages of two assays, with each assay performed in triplicate.

Since there are lower levels of gcvB expression in GM, GM supplemented with inosine, and GM with L-serine than in GM supplemented with glycine (33), we hypothesized the lower levels of GcvB under these conditions would result in higher levels of expression of the sstT-lacZ fusion. To test this hypothesis, the wild-type {lambda}sstT-lacZ lysogen was grown in GM, GM with inosine, GM with glycine, and GM with L-serine to the mid-log phase of growth and assayed for β-galactosidase activity. There was a small increase in sstT-lacZ expression in GM and GM supplemented with inosine compared to expression in GM with glycine (Fig. 3B). There was also higher expression of sstT-lacZ in GM supplemented with L-serine than in GM with glycine (Fig. 3B). Expression in GM plus L-serine was slightly lower than sstT-lacZ levels from GM or GM with inosine. Although the change is small, the results suggest that repression of gcvB does increase sstT-lacZ expression.

Region of sstT mRNA is important for negative regulation by GcvB. GcvB has a region of complementarity with the dppA and oppA mRNAs, two negatively regulated targets of GcvB (21). We hypothesized that a region of complementarity would exist between GcvB and sstT mRNA, but we were unable to identify a region of significant complementarity using the TargetRNA program (30) and Clone Manager, version 6, software. Therefore, to determine which region of sstT mRNA is required for negative regulation by GcvB, we made a series of transcriptional fusions of sstT with lacZ (Fig. 1A). The fusions were cloned into {lambda}gt2, and the phages were used to lysogenize the wild-type, {Delta}gcvB, and complemented {Delta}gcvB pgcvB+ strains. The lysogens were grown in LB medium to the mid-log phase of growth and assayed for β-galactosidase activity. We did not observe any significant regulation by GcvB with the {lambda}sstT(–66)-lacZ, {lambda}sstT(–40)-lacZ, or {lambda}sstT(–24)-lacZ fusion (Fig. 2B). However, there were decreases of approximately four- and eightfold in β-galactosidase activity in the {lambda}sstT(–40)-lacZ and {lambda}sstT(–24)-lacZ lysogens, respectively, compared with the {lambda}sstT(–66)-lacZ lysogens. These results suggest that a region of the sstT mRNA between nucleotides –66 and –24 is important for a GcvB-independent mechanism of regulation. In contrast to the –66, –40, and –24 lysogens, there were decreases of 3- and a 3.5-fold in β-galactosidase activity from the {lambda}sstT(–18)-lacZ and {lambda}sstT (–13)-lacZ fusions, respectively, in both the wild-type and the complemented {Delta}gcvB pgcvB+ lysogens compared with the {Delta}gcvB lysogen (Fig. 2B). This suggests that the region of sstT mRNA between the {lambda}sstT(–24)-lacZ and {lambda}sstT(–13)-lacZ fusions is necessary for negative regulation by GcvB. We did not observe the 12-fold range of regulation observed using the translational fusion (Fig. 2A), suggesting that additional sequence from the sstT mRNA is needed for full GcvB regulation.

Effects of mutations in gcvB on sstT-lacZ expression in vivo. Most analyses of base pairing between sRNAs and target mRNAs began by either creating a series of large deletions in the sRNA or mutating a large region of the sRNA to determine the region essential for regulation (1, 5, 12). Once a region was identified in the sRNA as being important for regulation, specific single nucleotide mutations were made and analyzed, often leading to loss of regulation of the respective target mRNA. For GcvB, a different approach was taken. A region of GcvB was identified as complementary to dppA and oppA (21). In addition, eight different single-copy-number plasmids were constructed carrying mutations in gcvB to analyze GcvB regulation of dppA and oppA mRNAs (21). These mutations were generated to disrupt the predicted region of complementarity between GcvB and dppA or oppA mRNA. Many of the mutations resulted in only minor alterations in GcvB's ability to regulate oppA-phoA and dppA-lacZ (21); however, the GcvB(+79ACAAgAgAA) (where uppercase letters indicate a 7-nucleotide substitution at nucleotide +79, and lowercase letters represent wild-type sequence) and GcvB(+71CCC) mutant sRNAs resulted in an inability to fully repress dppA-lacZ or oppA-phoA as the β-galactosidase levels were 4- and 4.5-fold higher, respectively, and the alkaline phosphatase levels were 2-fold higher with both mutant sRNAs than levels in controls (21). Additionally, the GcvB(+65AA) mutant sRNA was found to affect only regulation of dppA-lacZ, with β-galactosidase levels threefold higher than in controls (21). We tested if any of these gcvB mutant alleles failed to regulate the sstT-lacZ translational fusion. The {Delta}gcvB strain lysogenized with {lambda}sstT-lacZ was transformed with each mutant plasmid and assayed for β-galactosidase activity (Fig. 2A). Two GcvB mutants, GcvB(+79ACAAgAgAA) and GcvB(+76AAA), were unable to repress sstT-lacZ (Fig. 2A). The GcvB(+79ACAAgAgAA) mutant sRNA resulted in a complete loss of repression of sstT-lacZ, while the GcvB(+76AAA) mutant sRNA, previously shown to have no significant effect on regulation of dppA-lacZ and oppA-phoA (21), resulted in β-galactosidase levels fivefold higher than the wild-type {lambda}sstT-lacZ lysogen (Fig. 2A, compare lane 1 with lanes 4 and 7). We previously showed by Northern analysis that the mutations did not significantly alter the levels of GcvB (21), suggesting that the differences in regulation of sstT-lacZ are not a result of a difference in GcvB RNA levels.

Inspection of the sstT and GcvB sequences using results from both of the transcriptional fusions and the gcvB(+79ACAAgAgAA) and gcvB(+76AAA) alleles revealed a small region of complementarity upstream of the translational start site for sstT that was largely disrupted by the gcvB(+79ACAAgAgAA) mutation and partially altered by the gcvB(+76AAA) mutation (Fig. 1B). This region of the sstT mRNA also spans the {lambda}sstT(–18)-lacZ and {lambda}sstT(–13)-lacZ transcriptional fusion sites that identified the region as necessary for GcvB regulation of sstT-lacZ (Fig. 1 and 2B). To determine which bases in the gcvB(+79ACAAgAgAA) mutation are responsible for loss of repression, we constructed several new gcvB mutations. Because sRNA of the GcvB mutant with a deletion of 11 nucleotides at position +83 [GcvB(+83{Delta}11)] showed wild-type levels of repression of sstT-lacZ and partially overlaps nucleotides mutated in GcvB(+79ACAAgAgAA), we assumed that bp +84, +86, and +87 in gcvB that were deleted in the gcvB(+83{Delta}11) allele are not necessary for regulation of sstT-lacZ (Fig. 1B). To determine which of the remaining four nucleotides defined by the GcvB(+79ACAAgAgAA) mutant sRNA are necessary for regulating sstT mRNA, we mutated each nucleotide individually in gcvB, generating the plasmids pGS625 [gcvB(+79C)], pGS626 [gcvB(+80C)], pGS627 [gcvB(+81C)], and pGS628 [gcvB(+82A)], as well as mutating all four nucleotides together, generating the plasmid pGS629 [gcvB(+79CCCA)] (Table 1 and Fig. 1B). We also mutated the five nucleotides that overlap between the mutant sRNAs GcvB(+79ACAAgAgAA) and GcvB(+83{Delta}11), generating the plasmid pGS630 [gcvB(+83UCUCC)] (Table 1 and Fig. 1B). The {Delta}gcvB strain lysogenized with the {lambda}sstT-lacZ translational fusion was transformed with each of these six mutant plasmids, and the transformants were grown in LB medium with Amp to the mid-log phase of growth and assayed for β-galactosidase activity. Four mutant sRNAs, GcvB(+79C), GcvB(+80C), GcvB(+81C), and GcvB(+82A), were able to repress sstT-lacZ similarly to both the wild-type and {Delta}gcvB pgcvB+ complemented lysogens (Fig. 2C, compare lanes 1 and 3 with lanes 4 to 7). The {Delta}gcvB lysogen carrying the mutant sRNA GcvB(+79CCCA) showed ~1.5-fold higher activity than the wild-type, while the {Delta}gcvB lysogen carrying the mutant sRNA GcvB(+83UCUCC) had fivefold higher β-galactosidase activity than either the wild-type or complemented {Delta}gcvB pgcvB+ lysogens (Fig. 2C, compare lanes 1 and 3 with lanes 8 and 9).

Effects of mutations made in gcvB on GcvB RNA production. It is possible that the normal repression of sstT-lacZ observed for the mutant gcvB(+79C), gcvB(+80C), gcvB(+81C), and gcvB(+82A) alleles and the loss of repression of sstT-lacZ observed for the mutant gcvB(+79CCCA) and gcvB(+83UCUCC) alleles are results of overexpression or underexpression of the mutant RNAs, respectively. To determine if each of the newly generated gcvB mutant alleles produces comparable amounts of GcvB, Northern blotting was performed. The blot showed roughly equivalent amounts of GcvB detected for each of the eight RNA samples tested (Fig. 4). These results and the previously reported Northern blot analysis of other gcvB mutant alleles (21) suggest that the normal repression or loss of repression observed for sstT-lacZ is likely not due to changes in the synthesis or initial stability of GcvB but is a direct effect of GcvB's role in regulation of sstT mRNA.


Figure 4
View larger version (32K):
[in this window]
[in a new window]

  		FIG. 4. Northern blot analysis of GcvB expressed from either wild-type cells or from plasmids carrying either a wild-type or mutant gcvB allele transformed in the {Delta}gcvB strain. Total cell RNA was isolated from each strain, run on an 8 M urea-8% polyacrylamide gel, and probed with either a digoxigenin-labeled GcvB or a 5S RNA-specific DNA probe. Total RNA extracts are as follows (strain and plasmid): wild-type (GS162), gcvB+ (GS1144 [pGS594]), gcvB(+79C) (GS1144 [pGS625]), gcvB(+80C) (GS1144 [pGS626]), gcvB(+81C) (GS1144 [pGS627]), gcvB(+82A) (GS1144 [pGS628]), gcvB(+79CCCA) (GS1144 [pGS629]), and gcvB(+83UCUCC) (GS1144 [pGS630]) (Fig. 1B and Table 1). RNA was quantified using the software Image Gauge, version 3.12. RNA from each mutant gcvB allele was compared to the GcvB RNA expressed from the wild-type strain.

Effects of mutations in sstT-lacZ that restore base pairing to mutant GcvB on GcvB repression. The above results identified a region of GcvB complementary to sstT mRNA required for normal regulation. To determine whether GcvB regulates sstT mRNA by base pairing, a series of seven, five, or three nucleotides were changed in sstT-lacZ to restore base pairing with the gcvB(+79ACAAgAgAA), gcvB(+83UCUCC), and gcvB(+76AAA) mutant alleles (Fig. 1B). The changes UGUUcUcUU at nucleotides –14 to –22, AGAGG at nucleotides –18 to –22, and UUU at nucleotides –11 to –13 were made in sstT-lacZ (Fig. 1B). The fusions were cloned into {lambda}gt2, and the phages were used to lysogenize wild-type and {Delta}gcvB strains. The lysogens were grown in LB medium to the mid-log phase of growth and assayed for β-galactosidase activity. The wild-type strain lysogenized with {lambda}sstT(–18AGAGG)-lacZ produced β-galactosidase activity at a level similar to that of the wild-type strain lysogenized with {lambda}sstT-lacZ (Fig. 2D, compare lanes 1 and 3). However, the {Delta}gcvB {lambda}sstT(–18AGAGG)-lacZ lysogen showed β-galactosidase activity approximately twofold higher than that of the wild-type {lambda}sstT(–18AGAGG)-lacZ lysogen (Fig. 2D, compare lanes 3 and 4). The results suggest that the endogenous wild-type GcvB still regulates the sstT(–18AGAGG)-lacZ fusion over a twofold range, and the low level of expression from {lambda}sstT(–18AGAGG)-lacZ in the {Delta}gcvB strain is because the 5-nucleotide mutation to sstT affects the stability or translation of the fusion. We then tested to see if restoring base pairing between GcvB and {lambda}sstT(–18AGAGG)-lacZ would cause better repression by transforming the {Delta}gcvB {lambda}sstT(–18AGAGG)-lacZ lysogen with either pgcvB+ or pgcvB(+83UCUCC) and assaying for β-galactosidase activity. There was a modest decrease (~1.2-fold) in β-galactosidase activity when the strain was transformed with pgcvB+ or pgcvB(+83UCUCC) (Fig. 2D, compare lanes 4, 5, and 6), suggesting that both the wild-type and mutated GcvB(+83UCUCC) strains regulate equally and that the modest decrease was not due to the restoration of base pairing.

We next tested if a larger number of nucleotides are necessary for base pair regulation between GcvB and sstT by lysogenizing the wild-type and {Delta}gcvB strains with {lambda}sstT(–14UGUUcUcUU)-lacZ and assaying for β-galactosidase activity. The wild-type {lambda}sstT(–14UGUUcUcUU)-lacZ lysogen produced ~2.5-fold more β-galactosidase activity than the wild-type {lambda}sstT-lacZ lysogen, suggesting a loss of regulation by endogenous wild-type GcvB (Fig. 2D, compare lanes 1 and 7). The {Delta}gcvB {lambda}sstT(–14UGUUcUcUU)-lacZ lysogen produced approximately twofold higher levels of β-galactosidase than the wild-type {lambda}sstT(–14UGUUcUcUU)-lacZ lysogen (Fig. 2D, compare lanes 7 and 8). The low level of expression from {lambda}sstT(–14UGUUcUcUU)-lacZ in the {Delta}gcvB strain compared to the {lambda}sstT-lacZ lysogen is likely due to mutations in sstT that alter the stability or translation of the fusion (Fig. 2D, compare lanes 2 and 8). Despite lower overall levels of β-galactosidase activity, the {Delta}gcvB {lambda}sstT(–14UGUUcUcUU)-lacZ lysogen was transformed with pgcvB+ or pgcvB(+79ACAAgAgAA), and the transformants were assayed for β-galactosidase activity to see if restoration of base pairing was able to restore GcvB repression of sstT mRNA. When the {Delta}gcvB {lambda}sstT(–14UGUUcUcUU)-lacZ lysogen was transformed with pgcvB+ and pgcvB(+79ACAAgAgAA), there were 1.2- and 1.7-fold lower levels of β-galactosidase, respectively (Fig. 2D, compare lanes 8, 9, and 10).

Next, wild-type and {Delta}gcvB strains were lysogenized with {lambda}sstT(–11UUU)-lacZ, and the lysogens were assayed for β-galactosidase activity. The wild-type {lambda}sstT(–11UUU)-lacZ lysogen produced much lower β-galactosidase activity levels than previously assayed strains (Fig. 2E). This lower β-galactosidase activity is likely a result of the three mutated nucleotides in sstT that occur near the translational start site (Fig. 1B) and are predicted to alter the Shine-Dalgarno sequence as well as alter the secondary structure of sstT mRNA, allowing the Shine-Dalgarno sequence to possibly form part of a stem-loop structure (Fig. 5A and B). Interestingly, β-galactosidase levels from the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen decreased approximately twofold compared with the wild-type {lambda}sstT(–11UUU)-lacZ lysogen (Fig. 2E). When {Delta}gcvB {lambda}sstT(–11UUU)-lacZ was transformed with pgcvB+, a further decrease in β-galactosidase activity was observed (Fig. 2E). When the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen was transformed with pgcvB(+76AAA), which restored base pairing with the mutant sstT(–11UUU)-lacZ lysogen, β-galactosidase activity increased ~3.8-fold compared to the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen and ~2-fold compared with the wild-type {lambda}sstT(–11UUU)-lacZ lysogen (Fig. 2E).


Figure 5
View larger version (14K):
[in this window]
[in a new window]

  		FIG. 5. The predicted secondary structure of wild-type sstT (A) and mutated sstT(–11UUU) (B) mRNAs starting from the transcriptional start site of sstT 81 nucleotides upstream of the AUG translational start codon. Both secondary structures are based on Mfold predictions (42). Bases shown with a gray background indicate nucleotides predicted to base pair with GcvB (A) or GcvB(+76AAA) (B). The predicted {Delta}G values are –17.2 kcal mol–1 for wild-type sstT and –21.6 kcal mol–1 for mutated sstT(–11UUU).

Effects of inactivation of hfq or of both gcvB and hfq on {lambda}sstT-lacZ expression. It has been reported that many sRNAs that use RNA pairing to regulate require the Hfq RNA chaperone protein (26, 40). We observed that a deletion of hfq results in reduced repression of dppA-lacZ and oppA-phoA in E. coli (Pulvermacher et al., unpublished). A similar loss of regulation of dppA-gfp was reported in an E. coli hfq mutant (31), and the deletion of hfq in Salmonella enterica serovar Typhimurium resulted in a loss of regulation of OppA (24). Additionally, microarray analysis comparing the wild-type with a {Delta}hfq strain found that sstT mRNA was negatively regulated in the wild-type strain (9), suggesting that Hfq is necessary for regulation of sstT mRNA. Since the above results suggest that GcvB regulates sstT mRNA, we tested if Hfq is necessary for GcvB to regulate sstT mRNA. The wild-type, {Delta}hfq, {Delta}gcvAB {Delta}hfq, and the complemented {Delta}hfq phfq++ {lambda}sstT-lacZ lysogens were grown in LB medium to the mid-log phase of growth and assayed for β-galactosidase activity. β-Galactosidase activity expressed from sstT-lacZ in the wild-type lysogen was approximately eightfold lower than in the {Delta}hfq lysogen, and repression was restored in the complemented {Delta}hfq phfq++ (multicopy) lysogen (Fig. 2F). Additionally, when both gcvB and hfq were inactivated, β-galactosidase activity was nearly 11-fold higher than in the wild-type {lambda}sstT-lacZ lysogen (Fig. 2F). These results confirm that Hfq is required for GcvB-mediated repression of sstT-lacZ in cells grown in LB medium.

We also tested if Hfq is required for GcvB regulation of sstT in GM supplemented with glycine. The wild-type, {Delta}hfq, {Delta}gcvAB {Delta}hfq, and complemented {Delta}hfq phfq++ lysogens were grown in GM with glycine to the mid-log phase of growth and assayed for β-galactosidase activity. β-Galactosidase activity in the wild-type lysogen was approximately twofold lower than in the {Delta}hfq lysogen, and repression was restored in the complemented {Delta}hfq phfq++ lysogen (Fig. 3A). When both gcvB and hfq were inactivated, β-galactosidase activity from sstT-lacZ was approximately threefold higher than the levels produced from the wild-type lysogen (Fig. 3A). These results suggest Hfq is required for GcvB-mediated regulation of sstT mRNA in both LB medium and GM supplemented with glycine.

Effects on growth of wild-type and {Delta}gcvB strains in GM supplemented with serine. We have shown that GcvB negatively regulates sstT mRNA, encoding a protein that transports L-serine into the cell. In addition, we have found that GcvB negatively regulates livJ mRNA, encoding a periplasmic binding protein that also transports L-serine into the cell (data not shown) (14). Growth of E. coli in GM is inhibited by the addition of a low concentration of serine (less than 1 mM) (18). Because two of the four known serine transport mechanisms are negatively regulated by GcvB, we hypothesized that a {Delta}gcvB strain would have increased L-serine transport and enhanced growth inhibition compared with either the wild-type strain or the complemented {Delta}gcvB pgcvB+ strain when grown in GM supplemented with L-serine. Initially we tested if L-serine alters the level of gcvB expression. A low level of gcvB expression might mimic a {Delta}gcvB allele. β-Galactosidase levels from the wild-type strain carrying a {lambda}gcvB-lacZ transcriptional fusion were approximately twofold higher when cells were grown in GM supplemented with L-serine than when cells were grown in GM or GM with inosine (data not shown), suggesting that transcription of GcvB is slightly induced in the presence of L-serine but not to the same extent as in GM with glycine. Growth curves were then performed for wild-type, {Delta}gcvB, and complemented {Delta}gcvB pgcvB+ strains grown in GM and GM supplemented with L-serine. There was no significant difference in the growth of the three stains in GM (Fig. 6A). However, the {Delta}gcvB strain had a longer lag and grew considerably more slowly than the wild-type and the {Delta}gcvB pgcvB+ strains in GM with L-serine (Fig. 6B).


Figure 6
View larger version (22K):
[in this window]
[in a new window]

  		FIG. 6. The wild-type (GS162), {Delta}gcvB (GS1144), and complemented {Delta}gcvB pgcvB+ (GS1144 [pGS594]) strains were grown overnight in GM. Cultures were reinoculated in either 5 ml of GM (A) or 5 ml of GM with L-serine (B) (400 µg ml–1; transformants also had Amp added), and bacterial growth was monitored every 30 min by using a Klett-Summerson reader. Growth curves were conducted three separate times, and the averages are presented here.


arrow
DISCUSSION
 
Microarray analysis identified the sstT mRNA as a putative regulatory target of GcvB in E. coli cells grown in LB medium. Reverse transcription-PCR and lacZ fusions verified that sstT mRNA is negatively regulated by GcvB in LB medium. SstT is a transport protein involved in transporting L-serine into cells (13, 18, 19). DppA and OppA, two other known targets of GcvB regulation in E. coli, are the periplasmic-binding protein components of the two major peptide transport systems that are repressed in cells grown in rich medium (33). Preliminary results suggest that the cycA gene, encoding the E. coli glycine transport system, is also negatively regulated by GcvB in LB medium (S. C. Pulvermacher and G. V. Stauffer, unpublished results). It is possible that in E. coli GcvB plays a general role in repressing transport systems for small peptides and amino acids when nutrients are plentiful. In Salmonella, GcvB also directly interacts with seven mRNAs that encode different periplasmic binding proteins of ABC transporters (24). However, in neither organism was any gene previously identified that was regulated by GcvB in a defined medium. Results with the sstT-lacZ translational fusion are the first case of a target of GcvB regulated in defined medium. Although regulation in GM with glycine is not as robust as in LB medium (~2-fold versus ~12-fold), the results suggest that GcvB plays a role in regulating serine transport in defined medium.

Transcriptional fusions at bp –66, –40, and –24 relative to the translational start site of sstT were totally insensitive to regulation by GcvB (Fig. 2B). However, a transcriptional fusion at –18 in sstT showed 3-fold negative regulation by GcvB, and a transcriptional fusion at –13 in sstT showed 3.5-fold negative regulation by GcvB, suggesting that this region is required for normal GcvB control of sstT mRNA (Fig. 2B). Additional sstT sequence not carried in any of the five transcriptional fusions must be necessary to observe the ~12-fold regulation observed with the {lambda}sstT-lacZ translational fusion. An analysis of the GcvB sequence identified a short 7-nucleotide region complementary to the sstT mRNA overlapping the –18 and –13 transcriptional fusion sites (Fig. 1B). This is the same region of GcvB found to be complementary to, and necessary for, GcvB regulation of both the dppA and oppA mRNAs (21). The GcvB(+79ACAAgAgAA) mutant sRNA that resulted in a complete loss of GcvB regulation of sstT-lacZ disrupts a large portion of the predicted region of complementarity with sstT mRNA; this same GcvB mutant resulted in reduced repression of both dppA-lacZ and oppA-phoA (21). The GcvB(+76AAA) mutant sRNA resulted in a partial loss of GcvB regulation of sstT-lacZ and immediately flanks the 7-bp region and disrupts two additional nucleotides complementary to sstT mRNA near the Shine-Dalgarno sequence (Fig. 1B). Interestingly, the GcvB(+76AAA) mutant sRNA showed normal regulation of both dppA-lacZ and oppA-phoA (21). These results suggest that the nucleotides defined by these changes are involved in GcvB regulation of sstT mRNA. The GcvB(+83{Delta}11) mutant sRNA, which removes part of the 7-bp region of complementarity, as well as several nucleotides defined by the GcvB(+79ACAAgAgAA) mutant sRNA (Fig. 1B) had no affect on GcvB regulation of sstT-lacZ. The result suggests that nucleotides +76 to +82 that are changed by the GcvB(+79ACAAgAgAA) mutant sRNA but are not removed by the GcvB(+83{Delta}11) mutant sRNA are necessary for negative regulation of sstT mRNA. However, when nucleotides +79 to +82 were each changed individually, there was no effect on the repression of sstT-lacZ compared to wild-type GcvB (Fig. 2C, compare lane 3 with lanes 4 to 7). When all 4 nucleotides were changed together [pgcvB(+79CCCA)], there was a modest increase in sstT-lacZ expression compared to the wild-type (Fig. 2C, compare lanes 3 and 8). The other 5 nucleotides altered in GcvB(+79ACAAgAgAA) were mutated together in gcvB [pgcvB(+83UCUCC)] and resulted in a fivefold increase in β-galactosidase activity from sstT-lacZ compared to the wild-type (Fig. 2C, compare lanes 3 and 9). None of the various combinations of mutations in gcvB was able to produce the complete loss of regulation of sstT-lacZ observed for the GcvB(+79ACAAgAgAA) mutant sRNA. Even though Mfold predictions indicate that the gcvB(+79ACAAgAgAA) allele does not alter secondary structure, it is possible that in vivo the secondary structure is altered. If this occurs, the resulting loss of repression of sstT-lacZ would not depend on changed nucleotides of GcvB(+79ACAAgAgAA) no longer being able to base pair with sstT mRNA. Because GcvB(+79ACAAgAgAA) is still able to partially repress dppA-lacZ and oppA-phoA (21), we do not believe that the complete loss of regulation of sstT-lacZ by this mutant allele is due exclusively to potential changes in the secondary structure. We tested strains transformed with each plasmid carrying a mutant gcvB allele by Northern analysis to verify that equal amounts of GcvB RNA were produced. Since essentially equal amounts of GcvB were produced in each transformant, it is unlikely that changes in GcvB levels are responsible for any changes observed in sstT-lacZ expression. It seems that a large region of gcvB needs to be altered in order to produce a change in the ability of GcvB to regulate sstT-lacZ. The results do not rule out the possibility that the changes in gcvB alter regulation of an additional factor necessary for sstT regulation. Results with the transcriptional fusions suggest that an additional GcvB-independent factor is required for full sstT expression (Fig. 2B).

An alternative reason for the loss of repression of sstT-lacZ with the GcvB(+79ACAAgAgAA) mutant sRNA and not the GcvB(+83{Delta}11) mutant sRNA is that, despite the deletion of 11 nucleotides, the GcvB(+83{Delta}11) mutant sRNA remains GU rich while GcvB(+79ACAAgAgAA) has much of the GU-rich region changed to CA rich (Fig. 1B). This GU region has been shown to be important for regulation in Salmonella (24). It is possible that the GcvB(+83{Delta}11) mutant sRNA is still able to base pair with and regulate sstT. This GU-rich region of GcvB also becomes more CA rich in the GcvB(+83UCUCC) mutant sRNA, possibly explaining why a loss in regulation of sstT-lacZ is observed even though this region was not originally predicted to have an effect based on the results of the GcvB(+83{Delta}11) mutant sRNA. We did not observe the full loss of regulation of sstT-lacZ by GcvB(+83UCUCC) compared with GcvB(+79ACAAgAgAA), likely because fewer interactions are predicted to be disrupted by GcvB(+83UCUCC).

We constructed sstT(–14UGUUcUcUU)-lacZ and sstT(–18AGAGG)-lacZ fusions to test if base pairing restored the ability of the mutant gcvB alleles to repress. Restoration of base pairing of sstT(–14UGUUcUcUU)-lacZ mRNA with the GcvB(+79ACAAgAgAA) sRNA allowed better repression than GcvB (Fig. 2D, compare lane 8 with lanes 9 and 10). However, restoration of base pairing between sstT(–18AGAGG)-lacZ and GcvB(+83UCUCC) did not increase the ability of GcvB to repress (Fig. 2D, compare lane 4 with lanes 5 and 6). Similarly, when compensatory mutations were made in dppA-lacZ or oppA-phoA to restore base pairing with GcvB mutants that failed to fully repress, in most but not all cases we observed better repression when base pairing was restored (21). Our results show that a large number of nucleotides need to be disrupted between GcvB and sstT mRNA before a loss of regulation is observed. Thus, GcvB differs in its ability to regulate target mRNAs compared with the sRNA SgrS and the target mRNA ptsG or the sRNA OxyS and the target mRNA fhlA, where a loss of regulation is observed with single nucleotide mutations made in either the sRNA or the target mRNA (1, 12). When compensatory mutations were made to restore base pairing between SgrS and ptsG or between OxyS and fhlA, regulation was fully restored (1, 12). Because multiple nucleotides need to be mutated in GcvB to observe a loss in repression of sstT-lacZ, the results suggest that there may be a level of redundancy in the GcvB sequence, allowing regulation to be maintained despite mutations in GcvB.

The sstT(–11UUU)-lacZ fusion has three nucleotides changed at the translational start site (Fig. 1B). These changes either destabilize sstT mRNA or reduce the translational efficiency as the β-galactosidase activity levels in the wild-type {lambda}sstT(–11UUU)-lacZ lysogen are only ~2 units, and activity in the wild-type {lambda}sstT-lacZ lysogen is ~40 units (Fig. 2D and E). Mfold predictions suggest that the secondary structure of sstT mRNA containing these three changes is altered compared with wild-type sstT, sstT(–14UGUUcUcUU), or sstT(–18AGAGG) mRNAs. Part of the Shine-Dalgarno sequence for sstT(–11UUU)-lacZ now potentially base pairs while the Shine-Dalgarno sequence for wild-type and other mutant alleles is predicted to be unpaired (Fig. 5 and data not shown). Interestingly, when complementary base pairing was restored between sstT(–11UUU)-lacZ and GcvB(+76AAA) in the {Delta}gcvB lysogen, we observed higher levels of β-galactosidase activity than in the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen. When the pgcvB+ or pgcvB(+65AA) alleles, which do not restore complementarity, were transformed into the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen, we observed a decrease in β-galactosidase activity compared with the {Delta}gcvB {lambda}sstT(–11UUU)-lacZ lysogen (Fig. 2E and data not shown). The results suggest that complementary base pairing between GcvB(+76AAA) and sstT(–11UUU)-lacZ is important for the positive regulation of sstT(–11UUU)-lacZ. Even though sstT(–11UUU)-lacZ is an artificial construct, it is unclear why we now observe positive regulation by GcvB. Although base pairing between GcvB(+76AAA) and sstT(–11UUU)-lacZ would disrupt the secondary structure that potentially sequesters the Shine-Dalgarno sequence, one would predict that this base pairing would also hinder ribosomes from binding to the mRNA (Fig. 5B). Further analysis needs to be performed to determine if other circumstances lead to positive regulation of sstT by GcvB. The results raise the possibility that GcvB both represses and activates certain genes under different environmental conditions. If changes in temperature, osmolarity, pH, etc., change the secondary structures of mRNA transcripts such as sstT, the changes could allow GcvB to assume a different regulatory role.

Previous results showed that sRNAs that regulate their target mRNAs by base pairing often require the RNA chaperone protein Hfq for regulation. Additionally, sstT mRNA was differentially regulated in the wild type compared to a {Delta}hfq strain (9), suggesting that Hfq is involved in sstT regulation. However, Hfq was not shown to directly bind sstT mRNA (41). We found that Hfq is necessary for negative regulation of sstT-lacZ in cells grown in LB medium and GM supplemented with glycine. In addition, we observed an increase in β-galactosidase activity from the {Delta}gcvAB {Delta}hfq double deletion strain compared to the {Delta}gcvB and {Delta}hfq single deletion strains grown in LB medium and GM with glycine (Fig. 2F and 3A). The increase in β-galactosidase activity was not additive, suggesting that GcvB and Hfq likely regulate sstT-lacZ by the same regulatory mechanism. However, the increased β-galactosidase activity in the {Delta}gcvAB {Delta}hfq double deletion suggests that an additional factor possibly plays a minor role in regulating sstT-lacZ. Although the {Delta}gcvAB {Delta}hfq double deletion also removes the gcvA gene, we observed that β-galactosidase expression in the {Delta}gcvAB {lambda}sstT-lacZ lysogen is similar to that of the {Delta}gcvB lysogen (data not shown). Thus, the increased activity is not due to the {Delta}gcvA mutation.

Because sstT mRNA is negatively regulated by GcvB, we hypothesized that loss of GcvB would increase L-serine transport in E. coli. The addition of L-serine to GM is known to temporarily inhibit growth in E. coli (34) due to an elevated rate of serine catabolism to pyruvate (27). High pyruvate levels cause acetohydroxy acid synthase isozyme I to synthesize almost entirely 2-acetolactate (on the pathway to valine-leucine) and synthesis of only 1 to 2% 2-aceto-2-hydroxybutyrate (on the pathway to isoleucine), leading to isoleucine restriction in the cell (27). Additionally, homoserine dehydrogenase I, an enzyme involved in threonine and isoleucine synthesis, has also been reported to be inhibited by L-serine (27). The inhibition of this enzyme in isoleucine synthesis would also contribute to L-serine sensitivity (27). We predicted that increased serine transport due to a gcvB deletion would enhance growth inhibition in GM with L-serine. As shown in Fig. 6, we observed a longer lag and a slower growth rate for the {Delta}gcvB strain than for both the wild-type and the complemented {Delta}gcvB pgcvB+ strains. This result is consistent with our finding that GcvB is involved in negatively regulating sstT-lacZ expression in GM supplemented with glycine in E. coli (Fig. 3). Since multiple amino acid transport systems, as well as the di- and oligopeptide transport systems, are either predicted to be or have been shown to be regulated by GcvB (21, 33) (Pulvermacher and Stauffer, unpublished data), it is likely that additional growth phenotypes occur in an E. coli {Delta}gcvB strain grown in GM supplemented with different amino acids and peptides. Transport systems often play roles in the regulation of gene expression (27); therefore, regulation of different transport systems is essential. Our results suggest that GcvB is likely a global regulator in E. coli for genes encoding proteins for the transport of these small nutrient molecules into the cell in both rich medium and in GM.


arrow
ACKNOWLEDGMENTS
 
This work was supported by Public Health Service Grant GM069506 from the National Institute of General Medical Sciences.

We thank G. Storz for strain GS081. Additionally, we thank Dan McCabe, who assisted with some Miller assays.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, University of Iowa, Iowa City, IA 52242. Phone: (319)335-7791. Fax: (319)335-9006. E-mail: george-stauffer{at}uiowa.edu Back

{triangledown} Published ahead of print on 24 October 2008. Back


arrow
REFERENCES
 
    1
  1. Altuvia, S., A. Zhang, L. Argaman, A. Tiwari, and G. Storz. 1998. The Escherichia coli OxyS regulatory RNA represses fhlA translation by blocking ribosome binding. EMBO J. 17:6069-6075.[CrossRef][Medline]
    2. 2
  2. Argaman, L., R. Hershberg, J. Vogel, G. Bejerano, E. G. Wagner, H. Margalit, and S. Altuvia. 2001. Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr. Biol. 11:941-950.[CrossRef][Medline]
    3. 3
  3. Casadaban, M. J., J. Chou, and S. N. Cohen. 1980. In vitro gene fusions that join an enzymatically active β-galactosidase segment to amino-terminal fragments of exogenous proteins: Escherichia coli plasmid vectors for the detection and cloning of translational initiation signals. J. Bacteriol. 143:971-980.[Abstract/Free Full Text]
    4. 4
  4. Chang, A. C., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156.[Abstract/Free Full Text]
    5. 5
  5. Chen, S., A. Zhang, L. B. Blyn, and G. Storz. 2004. MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli. J. Bacteriol. 186:6689-6697.[Abstract/Free Full Text]
    6. 6
  6. Engler-Blum, G., M. Meier, J. Frank, and G. A. Muller. 1993. Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal. Biochem. 210:235-244.[CrossRef][Medline]
    7. 7
  7. Gottesman, S. 2004. The small RNA regulators of Escherichia coli: roles and mechanisms. Annu. Rev. Microbiol. 58:303-328.[CrossRef][Medline]
    8. 8
  8. Gottesman, S. 2002. Stealth regulation: biological circuits with small RNA switches. Genes Dev. 16:2829-2842.[Free Full Text]
    9. 9
  9. Guisbert, E., V. A. Rhodius, N. Ahuja, E. Witkin, and C. A. Gross. 2007. Hfq modulates the {sigma}E-mediated envelope stress response and the {sigma}32-mediated cytoplasmic stress response in Escherichia coli. J. Bacteriol. 189:1963-1973.[Abstract/Free Full Text]
    10. 10
  10. Jourdan, A. D., and G. V. Stauffer. 1999. Genetic analysis of the GcvA binding site in the gcvA control region. Microbiology 145:2153-2162.[Abstract/Free Full Text]
    11. 11
  11. Jourdan, A. D., and G. V. Stauffer. 1998. Mutational analysis of the transcriptional regulator GcvA: amino acids important for activation, repression, and DNA binding. J. Bacteriol. 180:4865-4871.[Abstract/Free Full Text]
    12. 12
  12. Kawamoto, H., Y. Koide, T. Morita, and H. Aiba. 2006. Base-pairing requirement for RNA silencing by a bacterial small RNA and acceleration of duplex formation by Hfq. Mol. Microbiol. 61:1013-1022.[CrossRef][Medline]
    13. 13
  13. Kim, Y. M., W. Ogawa, E. Tamai, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2002. Purification, reconstitution, and characterization of Na(+)/serine symporter, SstT, of Escherichia coli. J. Biochem. (Tokyo) 132:71-76.[Abstract/Free Full Text]
    14. 14
  14. Koyanagi, T., T. Katayama, H. Suzuki, and H. Kumagai. 2004. The LIV-I/LS system as a determinant of azaserine sensitivity of Escherichia coli K-12. FEMS Microbiol. Lett. 237:73-77.[CrossRef][Medline]
    15. 15
  15. Ledeboer, N. A., J. G. Frye, M. McClelland, and B. D. Jones. 2006. Salmonella enterica serovar Typhimurium requires the Lpf, Pef, and Tafi fimbriae for biofilm formation on HEp-2 tissue culture cells and chicken intestinal epithelium. Infect. Immun. 74:3156-3169.[Abstract/Free Full Text]
    16. 16
  16. Masse, E., C. K. Vanderpool, and S. Gottesman. 2005. Effect of RyhB small RNA on global iron use in Escherichia coli. J. Bacteriol. 187:6962-6971.[Abstract/Free Full Text]
    17. 17
  17. Miller, J. 1972. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    18. 18
  18. Ogawa, W., T. Kayahara, M. Tsuda, T. Mizushima, and T. Tsuchiya. 1997. Isolation and characterization of an Escherichia coli mutant lacking the major serine transporter, and cloning of a serine transporter gene. J. Biochem. (Tokyo) 122:1241-1245.[Abstract/Free Full Text]
    19. 19
  19. Ogawa, W., Y. M. Kim, T. Mizushima, and T. Tsuchiya. 1998. Cloning and expression of the gene for the Na+-coupled serine transporter from Escherichia coli and characteristics of the transporter. J. Bacteriol. 180:6749-6752.[Abstract/Free Full Text]
    20. 20
  20. Panasenko, S. M., J. R. Cameron, R. W. Davis, and I. R. Lehman. 1977. Five hundredfold overproduction of DNA ligase after induction of a hybrid lambda lysogen constructed in vitro. Science 196:188-189.[Abstract/Free Full Text]
    21. 21
  21. Pulvermacher, S. C., L. T. Stauffer, and G. V. Stauffer. 2008. The role of the small regulatory RNA GcvB in GcvB/mRNA posttranscriptional regulation of oppA and dppA in Escherichia coli. FEMS Microbiol. Lett. 281:42-50.[CrossRef][Medline]
    22. 22
  22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    23. 23
  23. Sarkar, G., and S. S. Sommer. 1990. The "megaprimer" method of site-directed mutagenesis. BioTechniques 8:404-407.[Medline]
    24. 24
  24. Sharma, C. M., F. Darfeuille, T. H. Plantinga, and J. Vogel. 2007. A small RNA regulates multiple ABC transporter mRNAs by targeting C/A-rich elements inside and upstream of ribosome-binding sites. Genes Dev. 21:2804-2817.[Abstract/Free Full Text]
    25. 25
  25. Shimada, K., R. A. Weisberg, and M. E. Gottesman. 1972. Prophage lambda at unusual chromosomal locations. I. Location of the secondary attachment sites and the properties of the lysogens. J. Mol. Biol. 63:483-503.[CrossRef][Medline]
    26. 26
  26. Sledjeski, D. D., C. Whitman, and A. Zhang. 2001. Hfq is necessary for regulation by the untranslated RNA DsrA. J. Bacteriol. 183:1997-2005.[Abstract/Free Full Text]
    27. 27
  27. Stauffer, G. V. 1983. Regulation of serine, glycine, and one-carbon biosynthesis, p. 103-113. In K. M. Herrmann and R. L. Somerville (ed.), Amino acids: biosynthesis and genetic regulation. Addison-Wesley Publishing Co., London, United Kingdom.
    28. 28
  28. Storz, G., S. Altuvia, and K. M. Wassarman. 2005. An abundance of RNA regulators. Annu. Rev. Biochem. 74:199-217.[CrossRef][Medline]
    29. 29
  29. Storz, G., J. A. Opdyke, and A. Zhang. 2004. Controlling mRNA stability and translation with small, noncoding RNAs. Curr. Opin. Microbiol. 7:140-144.[CrossRef][Medline]
    30. 30
  30. Tjaden, B., S. S. Goodwin, J. A. Opdyke, M. Guillier, D. X. Fu, S. Gottesman, and G. Storz. 2006. Target prediction for small, noncoding RNAs in bacteria. Nucleic Acids Res. 34:2791-2802.[Abstract/Free Full Text]
    31. 31
  31. Urban, J. H., and J. Vogel. 2007. Translational control and target recognition by Escherichia coli small RNAs in vivo. Nucleic Acids Res. 35:1018-1037.[Abstract/Free Full Text]
    32. 32
  32. Urbanowski, M. L., and G. V. Stauffer. 1986. Autoregulation by tandem promoters of the Salmonella typhimurium LT2 metJ gene. J. Bacteriol. 165:740-745.[Abstract/Free Full Text]
    33. 33
  33. Urbanowski, M. L., L. T. Stauffer, and G. V. Stauffer. 2000. The gcvB gene encodes a small untranslated RNA involved in expression of the dipeptide and oligopeptide transport systems in Escherichia coli. Mol. Microbiol. 37:856-868.[CrossRef][Medline]
    34. 34
  34. Uzan, M., and A. Danchin. 1978. Correlation between the serine sensitivity and the derepressibility of the ilv genes in Escherichia coli relA mutants. Mol. Gen. Genet. 165:21-30.[CrossRef][Medline]
    35. 35
  35. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.[Free Full Text]
    36. 36
  36. Wagner, E. G., and K. Flardh. 2002. Antisense RNAs everywhere? Trends Genet. 18:223-226.[CrossRef][Medline]
    37. 37
  37. Wassarman, K. M. 2002. Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell 109:141-144.[CrossRef][Medline]
    38. 38
  38. Wassarman, K. M., F. Repoila, C. Rosenow, G. Storz, and S. Gottesman. 2001. Identification of novel small RNAs using comparative genomics and microarrays. Genes Dev. 15:1637-1651.[Abstract/Free Full Text]
    39. 39
  39. Wassarman, K. M., A. Zhang, and G. Storz. 1999. Small RNAs in Escherichia coli. Trends Microbiol. 7:37-45.[CrossRef][Medline]
    40. 40
  40. Zhang, A., S. Altuvia, A. Tiwari, L. Argaman, R. Hengge-Aronis, and G. Storz. 1998. The OxyS regulatory RNA represses rpoS translation and binds the Hfq (HF-I) protein. EMBO J. 17:6061-6068.[CrossRef][Medline]
    41. 41
  41. Zhang, A., K. M. Wassarman, C. Rosenow, B. C. Tjaden, G. Storz, and S. Gottesman. 2003. Global analysis of small RNA and mRNA targets of Hfq. Mol. Microbiol. 50:1111-1124.[CrossRef][Medline]
    42. 42
  42. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.[Abstract/Free Full Text]

Journal of Bacteriology, January 2009, p. 238-248, Vol. 191, No. 1
0021-9193/09/$08.00+0     doi:10.1128/JB.00915-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pulvermacher, S. C.
Right arrow Articles by Stauffer, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pulvermacher, S. C.
Right arrow Articles by Stauffer, G. V.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»